Subscribe to our Newsletters !!

    Vaccination

    What are antibody therapy and who is creating them for COVID-19?

    While some potential immunizations have developed in the worldwide race to figure out how to stop the spread of COVID-19, numerous researchers and specialists accept counter acting agent based treatments hold extraordinary guarantee for rewarding individuals previously contaminated with the ailment. HOW DO ANTIBODY THERAPIES WORK? These treatments use antibodies created by tainted people or

    Serum Institute contributing USD 100 million on potential COVID-19 immunization

    Serum Institute of India, the world’s biggest immunization producer, is contributing USD 100 million on a potential COVID-19 antibody being created at Oxford University, as indicated by an organization official. The Pune-based organization has joined forces with AstraZeneca, a British biopharma goliath, to guarantee impartial gracefully of the AZD1222 antibody portions to India just as

    Remdesivir eases back COVID-19 movement in macaques: Study

    Washington, Jun 10 (PTI) Early treatment with the antiviral medication remdesivir has been found to diminish viral load and forestall lung sickness in macaques contaminated with SARS-CoV-2 that causes COVID-19, as indicated by an examination. The discoveries, distributed in the diary Nature on Tuesday, bolster the early utilization of remdesivir treatment in patients with COVID-19

    IIT-KGP specialists create AI-based framework to follow social distancing

    A gathering of specialists at IIT-Kharagpur has built up a digital physical framework dependent on computerized reasoning for checking social removing in broad daylight puts, an authority said on Saturday. The group, under the authority of teacher Debashish Chakravarty and educator Aditya Bandopadhyay, has designed a minimal effort gadget which can recognize the hole between

    China’s’ Sinovac says its coronavirus antibody demonstrated positive outcomes in preliminaries

    Chinese vaccine manufacturer Sinovac Biotech has reported “positive starter” aftereffects of stage I and II clinical preliminaries for its COVID-19 immunization up-and-comer, CoronaVac, saying it can incite a positive resistant reaction. The stage I/II clinical preliminaries was planned as randomized, twofold visually impaired and fake treatment controlled examinations. Altogether, 743 solid volunteers, matured from 18